Pfizer submits initial data to FDA on its COVID-19 vaccine for kids 5-11

Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking emergency use authorization.